AMTA LABS LIMITED drugs

3 results
AMTA LABS LIMITED
Usage: Esomeprazole Magnesium Delayed-Release Capsules are indicated for treating erosive esophagitis, GERD symptoms, NSAID-associated gastric ulcers, H. pylori eradication to prevent duodenal ulcers, and long-term management of pathological hypersecretory conditions like Zollinger-Ellison Syndrome. Treatment durations vary from short-term to long-term based on the condition.
AMTA LABS LIMITED
Usage: Mycophenolic Acid Delayed-Release Tablets are indicated for the prophylaxis of organ rejection in adult and pediatric patients (5 years and older) post-kidney transplant, used in combination with cyclosporine and corticosteroids. Interchange with mycophenolate mofetil products requires physician supervision due to differing absorption rates.
AMTA LABS LIMITED
Usage: This drug is indicated for treating hypokalemia, particularly in patients with digitalis intoxication and in hypokalemic familial periodic paralysis. It is also used to prevent hypokalemia in at-risk patients, especially those with significant cardiac arrhythmias, and should be reserved for those unable to tolerate liquid potassium preparations.